NASDAQ:CNMD

Conmed Stock Insider Trading

Healthcare > Medical - Devices

Buy CNMD

*Your capital is at risk

$35.16

+0.0300 (+0.0854%)

At Close: Jun 05, 2026

CONMED Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 77.42. In total, the insiders bought 492.73K and sold 12.38K CNMD shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	77.42
● Buy	492.73K shares
● Sell	12.38K shares
88% Buy Activity Moderate Negative Correlation
Buy Signal High Confidence Jun 01, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 77.42. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (88% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 03, 2025 Buy	RSUs (Restricted Stock Units) M-Exempt	Concannon Brian Director	Director	479 Value: $27.3K
Jun 03, 2025 Buy	Common Stock M-Exempt	Concannon Brian Director	Director	479 Value: $27.3K
Jun 03, 2025 Buy	RSUs (Restricted Stock Units) M-Exempt	Schwarzentraub Barbara J Director	Director	479 Value: $27.3K
Jun 03, 2025 Buy	Common Stock M-Exempt	Schwarzentraub Barbara J Director	Director	479 Value: $27.3K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Schwarzentraub Barbara J Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Schwarzentraub Barbara J Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Kaye Mark Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Kaye Mark Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Concannon Brian Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Concannon Brian Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Farkas Charles Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Farkas Charles Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Council Laverne H Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Council Laverne H Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Bronson David M. Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Bronson David M. Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Council Laverne H Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Council Laverne H Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Farkas Charles Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Farkas Charles Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Concannon Brian Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Concannon Brian Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Kaye Mark Director	Director	668 Value: $37.0K
Jun 02, 2025 Buy	Options To Purchase Common Stock A-Award	Kaye Mark Director	Director	8 061 Value: $446.4K
Jun 02, 2025 Buy	RSUs (Restricted Stock Units) A-Award	Schwarzentraub Barbara J Director	Director	668 Value: $37.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CONMED CORPORATION

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as suppor...

Read Full Profile Here